Duane Peters from the Lupus Foundation of America interviews Dr Stephen Balevic, Dr Rachel Randell and Professor Laura Schanberg from Duke University ...
EULAR 2021 eCongress Highlights
Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discus...
Safety profile of anifrolumab in SLE patients
Duane Peters from the Lupus Foundation of America interviews Professor Eric Morand from Monash University in Australia and Dr Raj Tummala from AstraZe...
The ALPHA Project
Duane Peters from the Lupus Foundation of America interviews Dr Susan Manzi from the Allegheny Health Network and Kathleen Arntsen from the Lupus and ...
Lupus Academy 10th Annual Meeting Highlights
Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discus...
Lupus Academy Tenth Annual Meeting Preview
Duane Peters of the Lupus Society of America interviews Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers about the 10th An...
Apolipoprotein L1 risk genotypes in Ghanaian patients
Duane Peters from the Lupus Foundation of America interviews Dr Ashira Blazer from New York University, USA, and Dr Ida Dzifa Dey from the University ...
Anti-Müllerian hormone in African- American women with SLE
Duane Peters from the Lupus Foundation of America interviews Ms Meghan Angley and Dr Sam Lim from Emory University in Georgia, and Dr Megan Clowse fro...
Efficacy and safety of rituximab biosimilar in refractory lupus
Duane Peters from the Lupus Foundation of America interviews Dr Pintip Ngamjanyaporn and Dr Nantakarn Pongtarakulpanit from Mahidol University in Bang...
Metabolic syndrome in SLE patients
Duane Peters from the Lupus Foundation of America interviews Dr Diane Apostolopoulos and Dr Eric Morand from Monash Health in Australia about their st...